uniQure N.V.: A Potential Huntington's Play

Live Chat on The Biotech Forum has been dominated by discussion of lucrative buy-write or covered call opportunities on selected biotech stocks over the past several months. To see what I and the other season biotech investors are targeting as trading ideas real-time, just join our community at The Biotech Forum by clicking HERE .Shares of gene therapy concern uniQure N.V. (NASDAQ: QURE ) have moved up significantly since bottoming in July 2024, as new data on Huntington's disease candidate AMT-130 were bot ...